Phase II trial of imatinib mesylate in patients with metastatic melanoma.
Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG.
Br J Cancer. 2008 Sep 2;99(5):734-40. Epub 2008 Aug 19.PMID: 18728664 [PubMed - indexed for MEDLINE]Related articlesFree article